These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31008285)

  • 1. Theophylline as an add-on to thrombolytic therapy in acute ischaemic stroke (TEA-Stroke): A randomized, double-blinded, placebo-controlled, two-centre phase II study.
    Modrau B; Hjort N; Østergaard L; Mouridsen K; Andersen G; Bach FW
    Eur Stroke J; 2016 Dec; 1(4):248-254. PubMed ID: 31008285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theophylline as an Add-On to Thrombolytic Therapy in Acute Ischemic Stroke: A Randomized Placebo-Controlled Trial.
    Modrau B; Andersen G; Mikkelsen IK; Nielsen A; Hansen MB; Johansen MB; Eskildsen HW; Povlsen JP; Yavarian Y; Mouridsen K; Østergaard L; Bach FW; Hjort N
    Stroke; 2020 Jul; 51(7):1983-1990. PubMed ID: 32568651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time is Penumbra: imaging, selection and outcome. The Johann jacob wepfer award 2014.
    Davis S; Donnan GA
    Cerebrovasc Dis; 2014; 38(1):59-72. PubMed ID: 25227260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
    Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion Changes in Acute Stroke Treated with Theophylline as an Add-on to Thrombolysis : A Randomized Clinical Trial Subgroup Analysis.
    Modrau B; Winder A; Hjort N; Nygård Johansen M; Andersen G; Fiehler J; Vorum H; Forkert ND
    Clin Neuroradiol; 2022 Jun; 32(2):345-352. PubMed ID: 34259904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).
    Ma H; Parsons MW; Christensen S; Campbell BC; Churilov L; Connelly A; Yan B; Bladin C; Phan T; Barber AP; Read S; Hankey GJ; Markus R; Wijeratne T; Grimley R; Mahant N; Kleinig T; Sturm J; Lee A; Blacker D; Gerraty R; Krause M; Desmond PM; McBride SJ; Carey L; Howells DW; Hsu CY; Davis SM; Donnan GA;
    Int J Stroke; 2012 Jan; 7(1):74-80. PubMed ID: 22188854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; Zoppo G; Yamaguchi T; Berge E
    Cochrane Database Syst Rev; 2003; (3):CD000213. PubMed ID: 12917889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine Learning-Based Prediction of Brain Tissue Infarction in Patients With Acute Ischemic Stroke Treated With Theophylline as an Add-On to Thrombolytic Therapy: A Randomized Clinical Trial Subgroup Analysis.
    Modrau B; Winder A; Hjort N; Johansen MN; Andersen G; Fiehler J; Vorum H; Forkert ND
    Front Neurol; 2021; 12():613029. PubMed ID: 34093387
    [No Abstract]   [Full Text] [Related]  

  • 10. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data.
    Campbell BCV; Majoie CBLM; Albers GW; Menon BK; Yassi N; Sharma G; van Zwam WH; van Oostenbrugge RJ; Demchuk AM; Guillemin F; White P; Dávalos A; van der Lugt A; Butcher KS; Cherifi A; Marquering HA; Cloud G; Macho Fernández JM; Madigan J; Oppenheim C; Donnan GA; Roos YBWEM; Shankar J; Lingsma H; Bonafé A; Raoult H; Hernández-Pérez M; Bharatha A; Jahan R; Jansen O; Richard S; Levy EI; Berkhemer OA; Soudant M; Aja L; Davis SM; Krings T; Tisserand M; San Román L; Tomasello A; Beumer D; Brown S; Liebeskind DS; Bracard S; Muir KW; Dippel DWJ; Goyal M; Saver JL; Jovin TG; Hill MD; Mitchell PJ;
    Lancet Neurol; 2019 Jan; 18(1):46-55. PubMed ID: 30413385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging.
    Davis SM; Donnan GA; Butcher KS; Parsons M
    Curr Opin Neurol; 2005 Feb; 18(1):47-52. PubMed ID: 15655402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extension of therapeutic window in ischemic stroke by selective mismatch imaging.
    Heiss WD; Zaro-Weber O
    Int J Stroke; 2019 Jun; 14(4):351-358. PubMed ID: 30935350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that determine penumbral tissue loss in acute ischaemic stroke.
    Jung S; Gilgen M; Slotboom J; El-Koussy M; Zubler C; Kiefer C; Luedi R; Mono ML; Heldner MR; Weck A; Mordasini P; Schroth G; Mattle HP; Arnold M; Gralla J; Fischer U
    Brain; 2013 Dec; 136(Pt 12):3554-60. PubMed ID: 24065722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoteplase.
    Paciaroni M; Medeiros E; Bogousslavsky J
    Expert Opin Biol Ther; 2009 Jun; 9(6):773-8. PubMed ID: 19456211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.
    Davis SM; Donnan GA; Parsons MW; Levi C; Butcher KS; Peeters A; Barber PA; Bladin C; De Silva DA; Byrnes G; Chalk JB; Fink JN; Kimber TE; Schultz D; Hand PJ; Frayne J; Hankey G; Muir K; Gerraty R; Tress BM; Desmond PM;
    Lancet Neurol; 2008 Apr; 7(4):299-309. PubMed ID: 18296121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
    Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
    Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild fever as a catalyst for consumption of the ischaemic penumbra despite endovascular reperfusion.
    Dehkharghani S; Yaghi S; Bowen MT; Pisani L; Scher E; Haussen DC; Nogueira RG
    Brain Commun; 2020; 2(2):fcaa116. PubMed ID: 33033801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; del Zoppo G; Yamaguchi T
    Cochrane Database Syst Rev; 2000; (2):CD000213. PubMed ID: 10796329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Cooperative Acute Stroke Study-4: Extending the time for thrombolysis in emergency neurological deficits ECASS-4: ExTEND.
    Amiri H; Bluhmki E; Bendszus M; Eschenfelder CC; Donnan GA; Leys D; Molina C; Ringleb PA; Schellinger PD; Schwab S; Toni D; Wahlgren N; Hacke W
    Int J Stroke; 2016 Feb; 11(2):260-7. PubMed ID: 26783318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.